„morpholine“
Suchergebnisse
524 Treffer
-
The crystal structure of dichlorido-(1,3-bis (2,6-dimethylphenyl)-1H-imidazol-2 (3H)-ylidene)-(morpholine-κ 1 N) palladium (II), C 23 H 29 Cl 2 N 3 OPd (II)
-
The crystal structure of dichlorido (1,3-dimesityl-1 H -3λ 4 -imidazol-2-yl)(morpholine-κN) palladium (IV), C 25 H 33 Cl 2 N 3 OPd
-
Crystal structure of 3,5-bis (trifluoromethyl) benzyl (Z)- N -(adamantan-1-yl) morpholine-4-carbothioimidate, C 24 H 28 F 6 N 2 OS
-
Crystal structure of (morpholine-1-carbodithioato-κ 2 - S, S ′) bis (triphenylphosphine-κ- P) gold (I), C 41 H 38 AuNOP 2 S 2
-
The crystal structure of bis (isothiocyanato-κ 1 N)-(methanol-κ 1 O)-(2-morpholine-4-yl-4,6-di (pyrazol-1-yl)-1,3,5-triazine-κ 3 N, N′, N′′) manganese (II), C 16 H 18 MnN 10 O 2 S 2
-
Exploring uncommon cyclization: Synthesis and crystal structure of a morpholine-substituted 1,2-pyrazole from Coumarin
-
Synthesis of Morpholine‐2,5‐Diones by Tandem of Azido‐Ugi and Ugi Reactions
-
CRYSTAL STRUCTURE OF AN ANTI-NEOPLASTIC AGENT, MORPHOLINE-4-CARBOXYBORANE, C5H12BNO3
-
The behaviour of two tricyclic fused host systems in the presence of four saturated six-membered ring guest solvents, dioxane, morpholine, piperidine and tetrahydropyran
-
Morpholin als ambidenter Ligand †
-
Trichloroberyllat‐Komplexe von Dimethylcyanamid, Morpholin und 4,4′‐Bipyridin †
-
Electroanalytical determination of peroxidases and laccases on carbon paste electrodes
-
Interfacial properties of morpholine-2,5-dione-based oligodepsipeptides and multiblock copolymers
-
Stereo‐ and Chemoselective Enrichment of sp 3 Character in Post‐Ugi Morpholines
-
Cyclooctyne End‐Functionalized Poly (morpholine‐2,5‐dione) s
-
Practical Catalytic Cleavage of C(sp3)−C(sp3) Bonds in Amines
-
Additive-Free Palladium-Catalysed Hydroamination of Piperylene with Morpholine
-
Progress in Depsipeptide‐Based Biomaterials
-
Design and Optimization of Novel Pyrimidine-Morpholine Hybrids Through Computational Approaches for SRC Kinase Inhibitory Activity
-
In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate [QMMSB]) and (quinolin-8-yl 4-methyl-3-((propan-2-yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing